Cynthia Lynn Anderson

CIK: 0001989905

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VTGN

Vistagen Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

VTGN
Vistagen Therapeutics, Inc.
Jun 30, 2025
Award(A)
Direct
6.6K shares at avg. $1.70$11K
VTGN
Vistagen Therapeutics, Inc.
Jun 23, 2025
Award(A)
Stock Option (Right to Buy)
Direct
100K shares-
VTGN
Vistagen Therapeutics, Inc.
Dec 31, 2024
Award(A)
Direct
2.6K shares at avg. $2.51$6K

		Type	Shares	Price		Ownership
Jun 30, 2025	VTGN Vistagen Therapeutics, Inc.	Award(A)	6,617	$1.70	$11,249	Direct
Jun 23, 2025	VTGN Vistagen Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	100,000	-	-	Direct
Dec 31, 2024	VTGN Vistagen Therapeutics, Inc.	Award(A)	2,592	$2.51	$6,499	Direct

1-3 of 3 transactions

About Anderson Cynthia Lynn

Anderson Cynthia Lynn (SEC CIK 0001989905) files insider reports with the SEC as CHIEF FINANCIAL OFFICER of Vistagen Therapeutics, Inc. (VTGN).

Signal8 holds 3 ownership filings by Anderson Cynthia Lynn, all Form 4s, filed between Jan 13, 2025 and Jul 1, 2025. Those filings report 3 transactions, from Dec 31, 2024 to Jun 30, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Anderson Cynthia Lynn's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Anderson Cynthia Lynn

Jun 30, 2025: Grant or award of VTGN shares (Form 4, code A).
Jun 23, 2025: Grant or award of VTGN derivative securities (Form 4, code A).
Dec 31, 2024: Grant or award of VTGN shares (Form 4, code A).

Other insiders filing for Vistagen Therapeutics, Inc. (VTGN)

Williamson Douglas J, Officer
Adler Reid G., Chief Legal Officer
Tressler Nick B., Chief Financial Officer
Singh Shawn, President and CEO
Angelov Angel S, Chief Medical Officer
Prince Joshua S., Chief Operating Officer

How to read Form 4 transaction codes